When nurse Pauline Cafferkey touched down in Glasgow in December 2014 after treating Ebola patients in Sierra Leone, she felt fine—yet within days, she was fighting for her life. Her case was one of just four in which someone unknowingly carried Ebola onto a commercial flight during the 2014–16 West Africa outbreak. Despite the fear that gripped global headlines at the time, she—and three others like her—remained the only known instances of latent Ebola cases leaving Africa in over half a century. Since 1976, only 28 confirmed Ebola cases have ever been recorded outside the continent, a strikingly small number given the scale and frequency of international travel. This data, compiled from 50 years of epidemiological records and published in Eurosurveillance in 2026, offers a reassuring truth: the risk of global Ebola spread is exceptionally low.
This matters not just for public health policy, but for how the world responds to fear. During outbreaks, calls for sweeping travel bans often dominate political discourse. Yet the evidence shows that only 25 of those 28 cases were primary imports—people who contracted the virus in Africa and were either medically evacuated or unknowingly traveled while asymptomatic. Just three secondary cases occurred, all in high-resource settings like the United States and Europe, where swift isolation and care prevented wider transmission. Of the four latent cases, none sparked an outbreak, even though they passed through screening undetected. These individuals included three health workers and one humanitarian volunteer—people returning from life-saving work, not vectors of uncontrolled spread.
The numbers tell a clear story: out of 300,000 travelers screened during the 2014–16 epidemic, only four were later diagnosed, and all were asymptomatic at the time of travel. The crude exportation risk since 2000? Just 0.17 cases per 1,000 reported Ebola infections in Africa—excluding medically evacuated patients. That’s less than two-tenths of a case for every thousand. The study’s authors, led by Kevin van Zandvoort, emphasize that existing WHO-recommended measures—exit screening in affected countries, monitoring for returning health workers, and infection prevention at the source—are highly effective. They also stress a deeper point: screening at departure points in outbreak zones is a shared global responsibility, one best supported by investing in local health infrastructure rather than closing borders.
As the world faces recurring outbreaks, including the 2026 Bundibugyo virus surge in the Democratic Republic of the Congo, this long-term data offers clarity. Fear may urge isolation, but evidence calls for support. With targeted measures and international cooperation, Ebola remains a tragic but containable threat—one that has, for 50 years, stayed largely where it began.